| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/29/2007 | CN100333722C Stable oil-in-water emulsion of propyl gallate for vein and its preparing method |
| 08/28/2007 | US7262317 Elastase inhibitor; respiratory system disorders; hypotensive agents; administering by injection |
| 08/28/2007 | US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1 |
| 08/28/2007 | US7262302 Antiinflammatory action; rheumatoid arthritis |
| 08/28/2007 | US7262293 precipitating from acidic aqueous solutions dropped into an aqueous or anhydrous solvents, then freeze drying to form amorphous salts having storage stability; monocyclic beta-lactam antibiotics |
| 08/28/2007 | US7262286 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 08/28/2007 | US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 08/28/2007 | US7262212 Antitubercular agent; antibiotic against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria; e.g. (R)-2-methyl-6-nitro-2-(4-(4-(4-trifluoromethoxyphenoxy)piperidin-1-yl)phenoxymethyl)-2,3-dihydroimidazo(2,1-b)oxazole |
| 08/28/2007 | US7262193 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
| 08/28/2007 | CA2450650C Encapsulated cell therapy |
| 08/28/2007 | CA2264693C Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 08/23/2007 | WO2007095043A2 Pharmaceutical formulations |
| 08/23/2007 | WO2007094423A1 Human monoclonal antibody capable of binding to human cytomegalovirus, and antigen-binding domain of the antibody |
| 08/23/2007 | WO2007093611A1 Fixed-dose association of phytate and zinc |
| 08/23/2007 | WO2007093608A1 Drug combinations for the treatment of respiratory tract diseases |
| 08/23/2007 | WO2007093557A1 Sulfonamide derivatives for the treatment of bacterial infections |
| 08/23/2007 | WO2007093183A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
| 08/23/2007 | WO2007093133A1 Sars vaccine based on replicative vaccinia virus vector |
| 08/23/2007 | WO2007071396A3 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 08/23/2007 | WO2007068473A3 Organic compounds |
| 08/23/2007 | WO2007066068A3 Calcium ion channel receptor antagonist |
| 08/23/2007 | US20070197656 reducing pro-inflammatory response in diseased cell of respiratory tract by contacting cell with an agent that increases ceramide levels in cell thereby reducing pro-inflammatory response in cell, wherein agent is fenretinide and diseased cell is representative of disease state of cystic fibrosis |
| 08/23/2007 | US20070197648 Pharmaceutical product containing tranilast |
| 08/23/2007 | US20070197644 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 08/23/2007 | US20070197601 Use of N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives in therapy |
| 08/23/2007 | US20070197570 Indanol derivative |
| 08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
| 08/23/2007 | US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone |
| 08/23/2007 | US20070197542 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/23/2007 | US20070197499 Pharmaceutical compounds |
| 08/23/2007 | US20070197496 for modulating cellular levels of oxidants such as superoxide radicals, hydrogen peroxide, peroxynitrite, lipid peroxides, hydroxyl radicals and thiyl radicals, treating diabetes mellitus Type I or Type II |
| 08/23/2007 | US20070197489 Composition of matter |
| 08/23/2007 | US20070196857 Determination of risk and treatment of complications of prematurity |
| 08/23/2007 | US20070196331 Methods and compositions for mobilizing stem cells |
| 08/23/2007 | US20070196286 Aerosol composition comprising formoterol |
| 08/23/2007 | CA2652648A1 Dihydrodiazepines useful as inhibitors of protein kinases |
| 08/23/2007 | CA2645734A1 Method of treating inflammatory diseases |
| 08/23/2007 | CA2642239A1 Drug combinations for the treatment of respiratory tract diseases |
| 08/23/2007 | CA2641216A1 Fixed-dose association of phytate and zinc |
| 08/23/2007 | CA2640304A1 Sulfonamide derivatives for the treatment of bacterial infections |
| 08/22/2007 | EP1820798A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 08/22/2007 | EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2007 | EP1820500A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 08/22/2007 | EP1819712A1 New pyridothienopyrimidine derivatives |
| 08/22/2007 | EP1819710A1 New pyridothienopyrimidine derivatives |
| 08/22/2007 | EP1819707A2 Substituted pteridines for the treatment of inflammatory diseases |
| 08/22/2007 | EP1819686A1 5-hydroxy-benzothiazole derivatives having beta-2-adrenorecptor agonist activity |
| 08/22/2007 | EP1819345A2 Use of lipid conjugates in the treatment of disease |
| 08/22/2007 | EP1819340A2 Methods and compositions for the treatment of pulmonary hypertension of the newborn |
| 08/22/2007 | EP1819329A2 Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases |
| 08/22/2007 | EP1567502B1 Substituted dihydrophenanthridinesul fonamides |
| 08/22/2007 | EP1499320B1 Novel compounds |
| 08/22/2007 | EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 08/22/2007 | EP1467728B1 Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 08/22/2007 | EP1453804B1 Ccr-3 receptor antagonists vii |
| 08/22/2007 | EP1448523B1 Heterocyclic compounds and methods of use |
| 08/22/2007 | EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS |
| 08/22/2007 | EP1178952B1 Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators |
| 08/22/2007 | EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 08/22/2007 | CN1332974C Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use |
| 08/22/2007 | CN1332968C Mangiferin derivatives and its prepn. method, and use as medicine |
| 08/22/2007 | CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 08/22/2007 | CN1332960C Imidazoquinoline derivatives as adenosine A3 receptor ligands |
| 08/22/2007 | CN1332715C Novel medicinal use of proteinase inhibior for preventing and curing lang disease |
| 08/22/2007 | CN1332714C Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist |
| 08/22/2007 | CN1332675C Medicine application of catalpa and extractive for anti allergic disease |
| 08/22/2007 | CN1332653C Snake gall pinellia drip pill and its preparation method |
| 08/22/2007 | CN101023083A Nitrogenous fused bicyclic compound |
| 08/22/2007 | CN101020039A Asthma treating hydrogel plaster prepn and its preparing process |
| 08/22/2007 | CN101020038A Asthma eliminating Sanshu ointment |
| 08/22/2007 | CN101020011A Pill for preventing and treating common cold |
| 08/22/2007 | CN101020009A Medicated teafor clearing away heat of pharynx and larynx |
| 08/22/2007 | CN101019996A Common cold treating capsule |
| 08/22/2007 | CN101019995A Medicine for treating pulmonary tuberculosis |
| 08/22/2007 | CN101019994A Chinese medicine for treating bronchial asthma and its prepn |
| 08/22/2007 | CN101019991A Common cold treating Chinese medicine and its prepn |
| 08/22/2007 | CN101019990A Chinese medicine for treating lobar pneumonia |
| 08/22/2007 | CN101019965A Common cold preventing medicine ointment and its prepn |
| 08/22/2007 | CN101019953A Medicine for treating bronchitis and asthma |
| 08/22/2007 | CN101019943A Tonsillitis treating Chinese medicine |
| 08/22/2007 | CN101019936A Chinese medicine prepn for treating wind-cold common cold |
| 08/22/2007 | CN101019921A Medicine composition for invigorating spleen and benefiting lung |
| 08/22/2007 | CN101019906A Chinese medicine for relieving cough, eliminating phlegm and relieving asthma |
| 08/22/2007 | CN101019901A Prepn process of cotton root extract health granule |
| 08/22/2007 | CN101019898A Crushing method and prepn of aweto |
| 08/22/2007 | CN101019893A Process of enriching effective antitumor part of periplaneta americana with polyamide |
| 08/22/2007 | CN101019876A Compound roxithromycin dispersing tablet and its prepn |
| 08/22/2007 | CN101019853A Composition containing dihomo-gamma-linolenic acid (DGLA) as the active ingredient |
| 08/22/2007 | CN101019826A Composition and great volume injection containing bromhexine salt and the injection preparing process |
| 08/22/2007 | CN101019627A Micro jet and instantaneous high pressure process of preparing whole lily powder |
| 08/22/2007 | CN101019588A Bagged lung heat eliminating tea |
| 08/21/2007 | US7259247 Against the costimulatory surface molecule, natural or synthetic ligands, agonists or antagonists of the surface molecule. |
| 08/21/2007 | US7259179 Kinase inhibitors |
| 08/21/2007 | US7259170 Macrolides containing pharmaceutical compositions |
| 08/21/2007 | US7259162 Benzazole derivatives and their use as JNK modulators |
| 08/21/2007 | US7259161 For therapy of immune response, an autoimmune disease, a neurodegenerative, or a solid or hematologic malignancy |
| 08/21/2007 | US7259154 Pyrrolopyrimidines |
| 08/21/2007 | US7258872 Chromone enteric release formulation |
| 08/21/2007 | US7258861 Peptides derived from the region of human TNF- alpha from Ser100 to Glu116 to treat pulmonary oedema. |